Click for best price
Broluzumab Biosimilars Market Size, Share 2022
Brolucizumab is a humanized single-chain antibody fragment for the treatment of neovascular (wet) age-related macular degeneration (AMD). The most common side effects are reduced visual acuity, cataract (clouding of the lens in the eye), conjunctival haemorrhage (bleeding at the front of the eye) and vitreous floaters (spots in the vision). The most serious side effects are blindness, endophthalmitis (an infection inside the eye), retinal artery occlusion (blockage of the artery in the retina) and retinal detachment (separation of the retina from the back of the eye). Brolucizumab was designed to attach to and block a substance called vascular endothelial growth factor A (VEGF-A). VEGF-A is a protein that makes blood vessels grow and leak fluid and blood, damaging the macula. By blocking VEGF-A, brolucizumab reduces the growth of the blood vessels and controls the leakage and swelling.
This report contains market size and forecasts of Broluzumab Biosimilars in global, including the following market information:
Global Broluzumab Biosimilars Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Broluzumab Biosimilars Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Broluzumab Biosimilars companies in 2021 (%)
The global Broluzumab Biosimilars market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Beovu Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Broluzumab Biosimilars include Novartis, Genentech, Roche, Pfizer, Sartorius, Eli Lilly, Bayer, Amgen and PlantForm, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Broluzumab Biosimilars manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Broluzumab Biosimilars Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Broluzumab Biosimilars Market Segment Percentages, by Type, 2021 (%)
Beovu
Vsiqq
Others
Global Broluzumab Biosimilars Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Broluzumab Biosimilars Market Segment Percentages, by Application, 2021 (%)
ARMD
Kaposi Sarcoma
Glioblastoma
Global Broluzumab Biosimilars Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Broluzumab Biosimilars Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Broluzumab Biosimilars revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Broluzumab Biosimilars revenues share in global market, 2021 (%)
Key companies Broluzumab Biosimilars sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Broluzumab Biosimilars sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Genentech
Roche
Pfizer
Sartorius
Eli Lilly
Bayer
Amgen
PlantForm
PharmaPraxis
Samsung Bioepis
Centus
Cadila Pharmaceuticals
Dr Reddy's
Aurobindo Pharma
Biocad
MAbxience
Hetero
Biocon
Kirin Biologics
Mylan
BeiGene
Innovent
Qilu Pharmaceutical
Hengrui Pharmaceuticals
Hisun Pharmaceutical
TOT BIOPHARM
Luye Pharmaceutical
Henlius
| Report Attributes |
Report Details |
| Report Title |
Broluzumab Biosimilars Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
125 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Broluzumab Biosimilars Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Broluzumab Biosimilars Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Broluzumab Biosimilars Overall Market Size
2.1 Global Broluzumab Biosimilars Market Size: 2021 VS 2028
2.2 Global Broluzumab Biosimilars Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Broluzumab Biosimilars Sales: 2017-2028
3 Company Landscape
3.1 Top Broluzumab Biosimilars Players in Global Market
3.2 Top Global Broluzumab Biosimilars Companies Ranked by Revenue
3.3 Global Broluzumab Biosimilars Revenue by Companies
3.4 Global Broluzumab Biosimilars Sales by Companies
3.5 Global Broluzumab Biosimilars Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Broluzumab Biosimilars Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Broluzumab Biosimilars Product Type
3.8 Tier 1, Tier 2 and Tier 3 Broluzumab Biosimilars Players in Global Market
3.8.1 List of Global Tier 1 Broluzumab Biosimilars Companies
3.8.2 List of Global Tier 2 and Tier 3 Broluzumab Biosimilars Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Broluzumab Biosimilars Market Size Markets, 2021 & 2028
4.1.2 Beovu
4.1.3 Vsiqq
4.1.4 Others
4.2 By Type - Global Broluzumab Biosimilars Revenue & Forecasts
4.2.1 By Type - Global Broluzumab Biosimilars Revenue, 2017-2022
4.2.2 By Type - Global Broluzumab Biosimilars Revenue, 2023-2028
4.2.3 By Type - Global Broluzumab Biosimilars Revenue Market Share, 2017-2028
4.3 By Type - Global Broluzumab Biosimilars Sales & Forecasts
4.3.1 By Type - Global Broluzumab Biosimilars Sales, 2017-2022
4.3.2 By Type - Global Broluzumab Biosimilars Sales, 2023-2028
4.3.3 By Type - Global Broluzumab Biosimilars Sales Market Share, 2017-2028
4.4 By Type - Global Broluzumab Biosimilars Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Broluzumab Biosimilars Market Size, 2021 & 2028
5.1.2 ARMD
5.1.3 Kaposi Sarcoma
5.1.4 Glioblastoma
5.2 By Application - Global Broluzumab Biosimilars Revenue & Forecasts
5.2.1 By Application - Global Broluzumab Biosimilars Revenue, 2017-2022
5.2.2 By Application - Global Broluzumab Biosimilars Revenue, 2023-2028
5.2.3 By Application - Global Broluzumab Biosimilars Revenue Market Share, 2017-2028
5.3 By Application - Global Broluzumab Biosimilars Sales & Forecasts
5.3.1 By Application - Global Broluzumab Biosimilars Sales, 2017-2022
5.3.2 By Application - Global Broluzumab Biosimilars Sales, 2023-2028
5.3.3 By Application - Global Broluzumab Biosimilars Sales Market Share, 2017-2028
5.4 By Application - Global Broluzumab Biosimilars Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Broluzumab Biosimilars Market Size, 2021 & 2028
6.2 By Region - Global Broluzumab Biosimilars Revenue & Forecasts
6.2.1 By Region - Global Broluzumab Biosimilars Revenue, 2017-2022
6.2.2 By Region - Global Broluzumab Biosimilars Revenue, 2023-2028
6.2.3 By Region - Global Broluzumab Biosimilars Revenue Market Share, 2017-2028
6.3 By Region - Global Broluzumab Biosimilars Sales & Forecasts
6.3.1 By Region - Global Broluzumab Biosimilars Sales, 2017-2022
6.3.2 By Region - Global Broluzumab Biosimilars Sales, 2023-2028
6.3.3 By Region - Global Broluzumab Biosimilars Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Broluzumab Biosimilars Revenue, 2017-2028
6.4.2 By Country - North America Broluzumab Biosimilars Sales, 2017-2028
6.4.3 US Broluzumab Biosimilars Market Size, 2017-2028
6.4.4 Canada Broluzumab Biosimilars Market Size, 2017-2028
6.4.5 Mexico Broluzumab Biosimilars Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Broluzumab Biosimilars Revenue, 2017-2028
6.5.2 By Country - Europe Broluzumab Biosimilars Sales, 2017-2028
6.5.3 Germany Broluzumab Biosimilars Market Size, 2017-2028
6.5.4 France Broluzumab Biosimilars Market Size, 2017-2028
6.5.5 U.K. Broluzumab Biosimilars Market Size, 2017-2028
6.5.6 Italy Broluzumab Biosimilars Market Size, 2017-2028
6.5.7 Russia Broluzumab Biosimilars Market Size, 2017-2028
6.5.8 Nordic Countries Broluzumab Biosimilars Market Size, 2017-2028
6.5.9 Benelux Broluzumab Biosimilars Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Broluzumab Biosimilars Revenue, 2017-2028
6.6.2 By Region - Asia Broluzumab Biosimilars Sales, 2017-2028
6.6.3 China Broluzumab Biosimilars Market Size, 2017-2028
6.6.4 Japan Broluzumab Biosimilars Market Size, 2017-2028
6.6.5 South Korea Broluzumab Biosimilars Market Size, 2017-2028
6.6.6 Southeast Asia Broluzumab Biosimilars Market Size, 2017-2028
6.6.7 India Broluzumab Biosimilars Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Broluzumab Biosimilars Revenue, 2017-2028
6.7.2 By Country - South America Broluzumab Biosimilars Sales, 2017-2028
6.7.3 Brazil Broluzumab Biosimilars Market Size, 2017-2028
6.7.4 Argentina Broluzumab Biosimilars Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Broluzumab Biosimilars Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Broluzumab Biosimilars Sales, 2017-2028
6.8.3 Turkey Broluzumab Biosimilars Market Size, 2017-2028
6.8.4 Israel Broluzumab Biosimilars Market Size, 2017-2028
6.8.5 Saudi Arabia Broluzumab Biosimilars Market Size, 2017-2028
6.8.6 UAE Broluzumab Biosimilars Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Novartis
7.1.1 Novartis Corporate Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Broluzumab Biosimilars Major Product Offerings
7.1.4 Novartis Broluzumab Biosimilars Sales and Revenue in Global (2017-2022)
7.1.5 Novartis Key News
7.2 Genentech
7.2.1 Genentech Corporate Summary
7.2.2 Genentech Business Overview
7.2.3 Genentech Broluzumab Biosimilars Major Product Offerings
7.2.4 Genentech Broluzumab Biosimilars Sales and Revenue in Global (2017-2022)
7.2.5 Genentech Key News
7.3 Roche
7.3.1 Roche Corporate Summary
7.3.2 Roche Business Overview
7.3.3 Roche Broluzumab Biosimilars Major Product Offerings
7.3.4 Roche Broluzumab Biosimilars Sales and Revenue in Global (2017-2022)
7.3.5 Roche Key News
7.4 Pfizer
7.4.1 Pfizer Corporate Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Broluzumab Biosimilars Major Product Offerings
7.4.4 Pfizer Broluzumab Biosimilars Sales and Revenue in Global (2017-2022)
7.4.5 Pfizer Key News
7.5 Sartorius
7.5.1 Sartorius Corporate Summary
7.5.2 Sartorius Business Overview
7.5.3 Sartorius Broluzumab Biosimilars Major Product Offerings
7.5.4 Sartorius Broluzumab Biosimilars Sales and Revenue in Global (2017-2022)
7.5.5 Sartorius Key News
7.6 Eli Lilly
7.6.1 Eli Lilly Corporate Summary
7.6.2 Eli Lilly Business Overview
7.6.3 Eli Lilly Broluzumab Biosimilars Major Product Offerings
7.6.4 Eli Lilly Broluzumab Biosimilars Sales and Revenue in Global (2017-2022)
7.6.5 Eli Lilly Key News
7.7 Bayer
7.7.1 Bayer Corporate Summary
7.7.2 Bayer Business Overview
7.7.3 Bayer Broluzumab Biosimilars Major Product Offerings
7.7.4 Bayer Broluzumab Biosimilars Sales and Revenue in Global (2017-2022)
7.7.5 Bayer Key News
7.8 Amgen
7.8.1 Amgen Corporate Summary
7.8.2 Amgen Business Overview
7.8.3 Amgen Broluzumab Biosimilars Major Product Offerings
7.8.4 Amgen Broluzumab Biosimilars Sales and Revenue in Global (2017-2022)
7.8.5 Amgen Key News
7.9 PlantForm
7.9.1 PlantForm Corporate Summary
7.9.2 PlantForm Business Overview
7.9.3 PlantForm Broluzumab Biosimilars Major Product Offerings
7.9.4 PlantForm Broluzumab Biosimilars Sales and Revenue in Global (2017-2022)
7.9.5 PlantForm Key News
7.10 PharmaPraxis
7.10.1 PharmaPraxis Corporate Summary
7.10.2 PharmaPraxis Business Overview
7.10.3 PharmaPraxis Broluzumab Biosimilars Major Product Offerings
7.10.4 PharmaPraxis Broluzumab Biosimilars Sales and Revenue in Global (2017-2022)
7.10.5 PharmaPraxis Key News
7.11 Samsung Bioepis
7.11.1 Samsung Bioepis Corporate Summary
7.11.2 Samsung Bioepis Broluzumab Biosimilars Business Overview
7.11.3 Samsung Bioepis Broluzumab Biosimilars Major Product Offerings
7.11.4 Samsung Bioepis Broluzumab Biosimilars Sales and Revenue in Global (2017-2022)
7.11.5 Samsung Bioepis Key News
7.12 Centus
7.12.1 Centus Corporate Summary
7.12.2 Centus Broluzumab Biosimilars Business Overview
7.12.3 Centus Broluzumab Biosimilars Major Product Offerings
7.12.4 Centus Broluzumab Biosimilars Sales and Revenue in Global (2017-2022)
7.12.5 Centus Key News
7.13 Cadila Pharmaceuticals
7.13.1 Cadila Pharmaceuticals Corporate Summary
7.13.2 Cadila Pharmaceuticals Broluzumab Biosimilars Business Overview
7.13.3 Cadila Pharmaceuticals Broluzumab Biosimilars Major Product Offerings
7.13.4 Cadila Pharmaceuticals Broluzumab Biosimilars Sales and Revenue in Global (2017-2022)
7.13.5 Cadila Pharmaceuticals Key News
7.14 Dr Reddy's
7.14.1 Dr Reddy's Corporate Summary
7.14.2 Dr Reddy's Business Overview
7.14.3 Dr Reddy's Broluzumab Biosimilars Major Product Offerings
7.14.4 Dr Reddy's Broluzumab Biosimilars Sales and Revenue in Global (2017-2022)
7.14.5 Dr Reddy's Key News
7.15 Aurobindo Pharma
7.15.1 Aurobindo Pharma Corporate Summary
7.15.2 Aurobindo Pharma Business Overview
7.15.3 Aurobindo Pharma Broluzumab Biosimilars Major Product Offerings
7.15.4 Aurobindo Pharma Broluzumab Biosimilars Sales and Revenue in Global (2017-2022)
7.15.5 Aurobindo Pharma Key News
7.16 Biocad
7.16.1 Biocad Corporate Summary
7.16.2 Biocad Business Overview
7.16.3 Biocad Broluzumab Biosimilars Major Product Offerings
7.16.4 Biocad Broluzumab Biosimilars Sales and Revenue in Global (2017-2022)
7.16.5 Biocad Key News
7.17 MAbxience
7.17.1 MAbxience Corporate Summary
7.17.2 MAbxience Business Overview
7.17.3 MAbxience Broluzumab Biosimilars Major Product Offerings
7.17.4 MAbxience Broluzumab Biosimilars Sales and Revenue in Global (2017-2022)
7.17.5 MAbxience Key News
7.18 Hetero
7.18.1 Hetero Corporate Summary
7.18.2 Hetero Business Overview
7.18.3 Hetero Broluzumab Biosimilars Major Product Offerings
7.18.4 Hetero Broluzumab Biosimilars Sales and Revenue in Global (2017-2022)
7.18.5 Hetero Key News
7.19 Biocon
7.19.1 Biocon Corporate Summary
7.19.2 Biocon Business Overview
7.19.3 Biocon Broluzumab Biosimilars Major Product Offerings
7.19.4 Biocon Broluzumab Biosimilars Sales and Revenue in Global (2017-2022)
7.19.5 Biocon Key News
7.20 Kirin Biologics
7.20.1 Kirin Biologics Corporate Summary
7.20.2 Kirin Biologics Business Overview
7.20.3 Kirin Biologics Broluzumab Biosimilars Major Product Offerings
7.20.4 Kirin Biologics Broluzumab Biosimilars Sales and Revenue in Global (2017-2022)
7.20.5 Kirin Biologics Key News
7.21 Mylan
7.21.1 Mylan Corporate Summary
7.21.2 Mylan Business Overview
7.21.3 Mylan Broluzumab Biosimilars Major Product Offerings
7.21.4 Mylan Broluzumab Biosimilars Sales and Revenue in Global (2017-2022)
7.21.5 Mylan Key News
7.22 BeiGene
7.22.1 BeiGene Corporate Summary
7.22.2 BeiGene Business Overview
7.22.3 BeiGene Broluzumab Biosimilars Major Product Offerings
7.22.4 BeiGene Broluzumab Biosimilars Sales and Revenue in Global (2017-2022)
7.22.5 BeiGene Key News
7.23 Innovent
7.23.1 Innovent Corporate Summary
7.23.2 Innovent Business Overview
7.23.3 Innovent Broluzumab Biosimilars Major Product Offerings
7.23.4 Innovent Broluzumab Biosimilars Sales and Revenue in Global (2017-2022)
7.23.5 Innovent Key News
7.24 Qilu Pharmaceutical
7.24.1 Qilu Pharmaceutical Corporate Summary
7.24.2 Qilu Pharmaceutical Business Overview
7.24.3 Qilu Pharmaceutical Broluzumab Biosimilars Major Product Offerings
7.24.4 Qilu Pharmaceutical Broluzumab Biosimilars Sales and Revenue in Global (2017-2022)
7.24.5 Qilu Pharmaceutical Key News
7.25 Hengrui Pharmaceuticals
7.25.1 Hengrui Pharmaceuticals Corporate Summary
7.25.2 Hengrui Pharmaceuticals Business Overview
7.25.3 Hengrui Pharmaceuticals Broluzumab Biosimilars Major Product Offerings
7.25.4 Hengrui Pharmaceuticals Broluzumab Biosimilars Sales and Revenue in Global (2017-2022)
7.25.5 Hengrui Pharmaceuticals Key News
7.26 Hisun Pharmaceutical
7.26.1 Hisun Pharmaceutical Corporate Summary
7.26.2 Hisun Pharmaceutical Business Overview
7.26.3 Hisun Pharmaceutical Broluzumab Biosimilars Major Product Offerings
7.26.4 Hisun Pharmaceutical Broluzumab Biosimilars Sales and Revenue in Global (2017-2022)
7.26.5 Hisun Pharmaceutical Key News
7.27 TOT BIOPHARM
7.27.1 TOT BIOPHARM Corporate Summary
7.27.2 TOT BIOPHARM Business Overview
7.27.3 TOT BIOPHARM Broluzumab Biosimilars Major Product Offerings
7.27.4 TOT BIOPHARM Broluzumab Biosimilars Sales and Revenue in Global (2017-2022)
7.27.5 TOT BIOPHARM Key News
7.28 Luye Pharmaceutical
7.28.1 Luye Pharmaceutical Corporate Summary
7.28.2 Luye Pharmaceutical Business Overview
7.28.3 Luye Pharmaceutical Broluzumab Biosimilars Major Product Offerings
7.28.4 Luye Pharmaceutical Broluzumab Biosimilars Sales and Revenue in Global (2017-2022)
7.28.5 Luye Pharmaceutical Key News
7.29 Henlius
7.29.1 Henlius Corporate Summary
7.29.2 Henlius Business Overview
7.29.3 Henlius Broluzumab Biosimilars Major Product Offerings
7.29.4 Henlius Broluzumab Biosimilars Sales and Revenue in Global (2017-2022)
7.29.5 Henlius Key News
8 Global Broluzumab Biosimilars Production Capacity, Analysis
8.1 Global Broluzumab Biosimilars Production Capacity, 2017-2028
8.2 Broluzumab Biosimilars Production Capacity of Key Manufacturers in Global Market
8.3 Global Broluzumab Biosimilars Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Broluzumab Biosimilars Supply Chain Analysis
10.1 Broluzumab Biosimilars Industry Value Chain
10.2 Broluzumab Biosimilars Upstream Market
10.3 Broluzumab Biosimilars Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Broluzumab Biosimilars Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Broluzumab Biosimilars in Global Market
Table 2. Top Broluzumab Biosimilars Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Broluzumab Biosimilars Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Broluzumab Biosimilars Revenue Share by Companies, 2017-2022
Table 5. Global Broluzumab Biosimilars Sales by Companies, (K Units), 2017-2022
Table 6. Global Broluzumab Biosimilars Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Broluzumab Biosimilars Price (2017-2022) & (K USD/Unit)
Table 8. Global Manufacturers Broluzumab Biosimilars Product Type
Table 9. List of Global Tier 1 Broluzumab Biosimilars Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Broluzumab Biosimilars Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Broluzumab Biosimilars Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Broluzumab Biosimilars Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Broluzumab Biosimilars Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Broluzumab Biosimilars Sales (K Units), 2017-2022
Table 15. By Type - Global Broluzumab Biosimilars Sales (K Units), 2023-2028
Table 16. By Application ? Global Broluzumab Biosimilars Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Broluzumab Biosimilars Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Broluzumab Biosimilars Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Broluzumab Biosimilars Sales (K Units), 2017-2022
Table 20. By Application - Global Broluzumab Biosimilars Sales (K Units), 2023-2028
Table 21. By Region ? Global Broluzumab Biosimilars Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Broluzumab Biosimilars Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Broluzumab Biosimilars Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Broluzumab Biosimilars Sales (K Units), 2017-2022
Table 25. By Region - Global Broluzumab Biosimilars Sales (K Units), 2023-2028
Table 26. By Country - North America Broluzumab Biosimilars Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Broluzumab Biosimilars Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Broluzumab Biosimilars Sales, (K Units), 2017-2022
Table 29. By Country - North America Broluzumab Biosimilars Sales, (K Units), 2023-2028
Table 30. By Country - Europe Broluzumab Biosimilars Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Broluzumab Biosimilars Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Broluzumab Biosimilars Sales, (K Units), 2017-2022
Table 33. By Country - Europe Broluzumab Biosimilars Sales, (K Units), 2023-2028
Table 34. By Region - Asia Broluzumab Biosimilars Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Broluzumab Biosimilars Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Broluzumab Biosimilars Sales, (K Units), 2017-2022
Table 37. By Region - Asia Broluzumab Biosimilars Sales, (K Units), 2023-2028
Table 38. By Country - South America Broluzumab Biosimilars Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Broluzumab Biosimilars Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Broluzumab Biosimilars Sales, (K Units), 2017-2022
Table 41. By Country - South America Broluzumab Biosimilars Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Broluzumab Biosimilars Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Broluzumab Biosimilars Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Broluzumab Biosimilars Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Broluzumab Biosimilars Sales, (K Units), 2023-2028
Table 46. Novartis Corporate Summary
Table 47. Novartis Broluzumab Biosimilars Product Offerings
Table 48. Novartis Broluzumab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
Table 49. Genentech Corporate Summary
Table 50. Genentech Broluzumab Biosimilars Product Offerings
Table 51. Genentech Broluzumab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
Table 52. Roche Corporate Summary
Table 53. Roche Broluzumab Biosimilars Product Offerings
Table 54. Roche Broluzumab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
Table 55. Pfizer Corporate Summary
Table 56. Pfizer Broluzumab Biosimilars Product Offerings
Table 57. Pfizer Broluzumab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
Table 58. Sartorius Corporate Summary
Table 59. Sartorius Broluzumab Biosimilars Product Offerings
Table 60. Sartorius Broluzumab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
Table 61. Eli Lilly Corporate Summary
Table 62. Eli Lilly Broluzumab Biosimilars Product Offerings
Table 63. Eli Lilly Broluzumab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
Table 64. Bayer Corporate Summary
Table 65. Bayer Broluzumab Biosimilars Product Offerings
Table 66. Bayer Broluzumab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
Table 67. Amgen Corporate Summary
Table 68. Amgen Broluzumab Biosimilars Product Offerings
Table 69. Amgen Broluzumab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
Table 70. PlantForm Corporate Summary
Table 71. PlantForm Broluzumab Biosimilars Product Offerings
Table 72. PlantForm Broluzumab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
Table 73. PharmaPraxis Corporate Summary
Table 74. PharmaPraxis Broluzumab Biosimilars Product Offerings
Table 75. PharmaPraxis Broluzumab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
Table 76. Samsung Bioepis Corporate Summary
Table 77. Samsung Bioepis Broluzumab Biosimilars Product Offerings
Table 78. Samsung Bioepis Broluzumab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
Table 79. Centus Corporate Summary
Table 80. Centus Broluzumab Biosimilars Product Offerings
Table 81. Centus Broluzumab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
Table 82. Cadila Pharmaceuticals Corporate Summary
Table 83. Cadila Pharmaceuticals Broluzumab Biosimilars Product Offerings
Table 84. Cadila Pharmaceuticals Broluzumab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
Table 85. Dr Reddy's Corporate Summary
Table 86. Dr Reddy's Broluzumab Biosimilars Product Offerings
Table 87. Dr Reddy's Broluzumab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
Table 88. Aurobindo Pharma Corporate Summary
Table 89. Aurobindo Pharma Broluzumab Biosimilars Product Offerings
Table 90. Aurobindo Pharma Broluzumab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
Table 91. Biocad Corporate Summary
Table 92. Biocad Broluzumab Biosimilars Product Offerings
Table 93. Biocad Broluzumab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
Table 94. MAbxience Corporate Summary
Table 95. MAbxience Broluzumab Biosimilars Product Offerings
Table 96. MAbxience Broluzumab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
Table 97. Hetero Corporate Summary
Table 98. Hetero Broluzumab Biosimilars Product Offerings
Table 99. Hetero Broluzumab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
Table 100. Biocon Corporate Summary
Table 101. Biocon Broluzumab Biosimilars Product Offerings
Table 102. Biocon Broluzumab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
Table 103. Kirin Biologics Corporate Summary
Table 104. Kirin Biologics Broluzumab Biosimilars Product Offerings
Table 105. Kirin Biologics Broluzumab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
Table 106. Mylan Corporate Summary
Table 107. Mylan Broluzumab Biosimilars Product Offerings
Table 108. Mylan Broluzumab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
Table 109. BeiGene Corporate Summary
Table 110. BeiGene Broluzumab Biosimilars Product Offerings
Table 111. BeiGene Broluzumab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
Table 112. Innovent Corporate Summary
Table 113. Innovent Broluzumab Biosimilars Product Offerings
Table 114. Innovent Broluzumab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
Table 115. Qilu Pharmaceutical Corporate Summary
Table 116. Qilu Pharmaceutical Broluzumab Biosimilars Product Offerings
Table 117. Qilu Pharmaceutical Broluzumab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
Table 118. Hengrui Pharmaceuticals Corporate Summary
Table 119. Hengrui Pharmaceuticals Broluzumab Biosimilars Product Offerings
Table 120. Hengrui Pharmaceuticals Broluzumab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
Table 121. Hisun Pharmaceutical Corporate Summary
Table 122. Hisun Pharmaceutical Broluzumab Biosimilars Product Offerings
Table 123. Hisun Pharmaceutical Broluzumab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
Table 124. TOT BIOPHARM Corporate Summary
Table 125. TOT BIOPHARM Broluzumab Biosimilars Product Offerings
Table 126. TOT BIOPHARM Broluzumab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
Table 127. Luye Pharmaceutical Corporate Summary
Table 128. Luye Pharmaceutical Broluzumab Biosimilars Product Offerings
Table 129. Luye Pharmaceutical Broluzumab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
Table 130. Henlius Corporate Summary
Table 131. Henlius Broluzumab Biosimilars Product Offerings
Table 132. Henlius Broluzumab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
Table 133. Broluzumab Biosimilars Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 134. Global Broluzumab Biosimilars Capacity Market Share of Key Manufacturers, 2020-2022
Table 135. Global Broluzumab Biosimilars Production by Region, 2017-2022 (K Units)
Table 136. Global Broluzumab Biosimilars Production by Region, 2023-2028 (K Units)
Table 137. Broluzumab Biosimilars Market Opportunities & Trends in Global Market
Table 138. Broluzumab Biosimilars Market Drivers in Global Market
Table 139. Broluzumab Biosimilars Market Restraints in Global Market
Table 140. Broluzumab Biosimilars Raw Materials
Table 141. Broluzumab Biosimilars Raw Materials Suppliers in Global Market
Table 142. Typical Broluzumab Biosimilars Downstream
Table 143. Broluzumab Biosimilars Downstream Clients in Global Market
Table 144. Broluzumab Biosimilars Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Broluzumab Biosimilars Segment by Type
Figure 2. Broluzumab Biosimilars Segment by Application
Figure 3. Global Broluzumab Biosimilars Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Broluzumab Biosimilars Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Broluzumab Biosimilars Revenue, 2017-2028 (US$, Mn)
Figure 7. Broluzumab Biosimilars Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Broluzumab Biosimilars Revenue in 2021
Figure 9. By Type - Global Broluzumab Biosimilars Sales Market Share, 2017-2028
Figure 10. By Type - Global Broluzumab Biosimilars Revenue Market Share, 2017-2028
Figure 11. By Type - Global Broluzumab Biosimilars Price (K USD/Unit), 2017-2028
Figure 12. By Application - Global Broluzumab Biosimilars Sales Market Share, 2017-2028
Figure 13. By Application - Global Broluzumab Biosimilars Revenue Market Share, 2017-2028
Figure 14. By Application - Global Broluzumab Biosimilars Price (K USD/Unit), 2017-2028
Figure 15. By Region - Global Broluzumab Biosimilars Sales Market Share, 2017-2028
Figure 16. By Region - Global Broluzumab Biosimilars Revenue Market Share, 2017-2028
Figure 17. By Country - North America Broluzumab Biosimilars Revenue Market Share, 2017-2028
Figure 18. By Country - North America Broluzumab Biosimilars Sales Market Share, 2017-2028
Figure 19. US Broluzumab Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Broluzumab Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Broluzumab Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Broluzumab Biosimilars Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Broluzumab Biosimilars Sales Market Share, 2017-2028
Figure 24. Germany Broluzumab Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 25. France Broluzumab Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Broluzumab Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Broluzumab Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Broluzumab Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Broluzumab Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Broluzumab Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Broluzumab Biosimilars Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Broluzumab Biosimilars Sales Market Share, 2017-2028
Figure 33. China Broluzumab Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Broluzumab Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Broluzumab Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Broluzumab Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 37. India Broluzumab Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Broluzumab Biosimilars Revenue Market Share, 2017-2028
Figure 39. By Country - South America Broluzumab Biosimilars Sales Market Share, 2017-2028
Figure 40. Brazil Broluzumab Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Broluzumab Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Broluzumab Biosimilars Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Broluzumab Biosimilars Sales Market Share, 2017-2028
Figure 44. Turkey Broluzumab Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Broluzumab Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Broluzumab Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Broluzumab Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 48. Global Broluzumab Biosimilars Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Broluzumab Biosimilars by Region, 2021 VS 2028
Figure 50. Broluzumab Biosimilars Industry Value Chain
Figure 51. Marketing Channels
